The abstract is read at the publisher; the summary is JClub's.
Group O recipients of group B or AB plasma or platelet concentrates with severe allergic transfusion reactions show substantially higher titers of group B cross-reactive anti-α-Gal IgE than other patients.
- Why it matters: Severe allergic transfusion reactions occur in up to 0.3% to 6% of plasma or platelet transfusions, and the mechanism beyond known IgE responses to donor proteins is unclear.
- What they did: In a cohort of 59 patients with severe ATR, anti-α-Gal IgE was measured, and group O recipients of group B/AB components were compared with other patients for high titers of group B cross-reactive anti-α-Gal IgE.
- The result: The association supports α-Gal sensitization as an additional mechanism linked to severe ATR in major ABO-incompatible transfusion, suggesting systematic exploration in group O patients after receiving group B/AB plasma or platelets.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.